Terms: = Sarcomas AND CBFB, PEBP2B, 865, ENSG00000067955, Q13951
31 results:
1. Reconstruction with a double-constrained implant design after complex shoulder extra-articular resection.
Lesensky J; Belzarena AC; Daniel M
World J Surg Oncol; 2023 Sep; 21(1):295. PubMed ID: 37723520
[TBL] [Abstract] [Full Text] [Related]
2. MSH-5: malignant knee tumors timely detection index.
Rivera-Saldívar G; Torres-González R; Cario-Méndez A; Técualt-Gómez R; Amaya-Zepeda RA; Alcántara-Corona A; Fuentes-Figueroa S
Cir Cir; 2023; 91(2):146-152. PubMed ID: 37084299
[TBL] [Abstract] [Full Text] [Related]
3. Which modality is better to diagnose high-grade transformation in retroperitoneal liposarcoma? Comparison of computed tomography, positron emission tomography, and magnetic resonance imaging.
Nakashima Y; Yokoyama Y; Ogawa H; Sakakibara A; Sunagawa M; Nishida Y; Mizuno T; Yamaguchi J; Onoe S; Watanabe N; Kawakatsu S; Igami T; Ebata T
Int J Clin Oncol; 2023 Mar; 28(3):482-490. PubMed ID: 36583836
[TBL] [Abstract] [Full Text] [Related]
4. Applications of the Grading Scales for the Detection of Ototoxicity in Children after Treatment of Neuroblastoma and Extracranial Germinal Tumor.
Polski B; Sosnowska-Sienkiewicz P; Szydłowski J; Januszkiewicz-Lewandowska D
Audiol Neurootol; 2023; 28(1):32-42. PubMed ID: 36191558
[TBL] [Abstract] [Full Text] [Related]
5. [Myeloid sarcomas of the shoulder and testis relapsing 9 years after allogenic stem cell transplantation for acute myeloid leukemia].
Yamamoto R; Suyama T; Yoshizawa Y; Shimizu M; Kuroda A; Shinagawa A
Rinsho Ketsueki; 2022; 63(8):860-864. PubMed ID: 36058855
[TBL] [Abstract] [Full Text] [Related]
6. Association of Family Cancer History With Pathogenic Variants in Specific Breast Cancer Susceptibility Genes.
Kurian AW; Abrahamse P; Ward KC; Hamilton AS; Deapen D; Berek JS; Hoang L; Yussuf A; Dolinsky J; Brown K; Slavin T; Hofer TP; Katz SJ
JCO Precis Oncol; 2021; 5():. PubMed ID: 34977446
[TBL] [Abstract] [Full Text] [Related]
7. Cancer incidence in the vicinity of a waste incineration plant in the Nice area between 2005 and 2014.
Mariné Barjoan E; Doulet N; Chaarana A; Festraëts J; Viot A; Ambrosetti D; Lasalle JL; Mounier N; Bailly L; Pradier C
Environ Res; 2020 Sep; 188():109681. PubMed ID: 32562946
[TBL] [Abstract] [Full Text] [Related]
8. Primary leiomyosarcoma of the uterine cervix: report of 4 cases, systematic review, and meta-analysis.
Kiliç C; Yuksel D; Cakir C; Turkmen O; Kimyon Comert G; Başaran D; Turan T
Tumori; 2020 Oct; 106(5):413-423. PubMed ID: 32403994
[TBL] [Abstract] [Full Text] [Related]
9. Myeloid Sarcoma With cbfb-MYH11 Fusion (inv(16) or t(16;16)) Prevails in the Abdomen.
Dalland JC; Meyer R; Ketterling RP; Reichard KK
Am J Clin Pathol; 2020 Feb; 153(3):333-341. PubMed ID: 31671434
[TBL] [Abstract] [Full Text] [Related]
10. Computerized texture analysis of pulmonary nodules in pediatric patients with osteosarcoma: Differentiation of pulmonary metastases from non-metastatic nodules.
Cho YJ; Kim WS; Choi YH; Ha JY; Lee S; Park SJ; Cheon JE; Kang HJ; Shin HY; Kim IO
PLoS One; 2019; 14(2):e0211969. PubMed ID: 30735557
[TBL] [Abstract] [Full Text] [Related]
11. Outcome after surgical treatment of dermatofibrosarcoma protuberans: Is clinical follow-up always indicated?
Huis In 't Veld EA; van Coevorden F; Grünhagen DJ; Smith MJ; van Akkooi ACJ; Wouters MWJM; Hayes AJ; Verhoef C; Strauss DC; van Houdt WJ
Cancer; 2019 Mar; 125(5):735-741. PubMed ID: 30644528
[TBL] [Abstract] [Full Text] [Related]
12. Incidence and groups at risk for unexpected uterine leiomyosarcoma: a Dutch nationwide cohort study.
van den Haak L; de Kroon CD; Warmerdam MI; Siebers AG; Rhemrev JP; Nieboer TE; Jansen FW
Arch Gynecol Obstet; 2019 Jan; 299(1):159-165. PubMed ID: 30498966
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study.
Claerhout H; Van Aelst S; Melis C; Tousseyn T; Gheysens O; Vandenberghe P; Dierickx D; Boeckx N
Eur J Haematol; 2018 Jun; 100(6):603-612. PubMed ID: 29532520
[TBL] [Abstract] [Full Text] [Related]
14. MRI Identification of the Osseous Extent of Pediatric Bone sarcomas.
Thompson MJ; Shapton JC; Punt SE; Johnson CN; Conrad EU
Clin Orthop Relat Res; 2018 Mar; 476(3):559-564. PubMed ID: 29529641
[TBL] [Abstract] [Full Text] [Related]
15. Quantitative estimated exposure to vinyl chloride and risk of angiosarcoma of the liver and hepatocellular cancer in the US industry-wide vinyl chloride cohort: mortality update through 2013.
Mundt KA; Dell LD; Crawford L; Gallagher AE
Occup Environ Med; 2017 Oct; 74(10):709-716. PubMed ID: 28490663
[TBL] [Abstract] [Full Text] [Related]
16. Location of residual viable tumor cells after neoadjuvant chemotherapy: A new concept with high prognostic performance in osteosarcoma.
Kim SH; Shin KH; Moon SH; Kong Y; Suh JS; Yang WI
J Surg Oncol; 2017 May; 115(6):752-759. PubMed ID: 28403564
[TBL] [Abstract] [Full Text] [Related]
17. Patients with soft tissue sarcoma comprise a higher probability of comorbidities than cancer-free individuals. A secondary data analysis.
Trautmann F; Singer S; Schmitt J
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 27957779
[TBL] [Abstract] [Full Text] [Related]
18. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial.
Piperno-Neumann S; Le Deley MC; Rédini F; Pacquement H; Marec-Bérard P; Petit P; Brisse H; Lervat C; Gentet JC; Entz-Werlé N; Italiano A; Corradini N; Bompas E; Penel N; Tabone MD; Gomez-Brouchet A; Guinebretière JM; Mascard E; Gouin F; Chevance A; Bonnet N; Blay JY; Brugières L; ; ;
Lancet Oncol; 2016 Aug; 17(8):1070-1080. PubMed ID: 27324280
[TBL] [Abstract] [Full Text] [Related]
19. Burden of soft-tissue and bone sarcoma in routine care: Estimation of incidence, prevalence and survival for health services research.
Trautmann F; Schuler M; Schmitt J
Cancer Epidemiol; 2015 Jun; 39(3):440-6. PubMed ID: 25801944
[TBL] [Abstract] [Full Text] [Related]
20. Genotyping cancer-associated genes in chordoma identifies mutations in oncogenes and areas of chromosomal loss involving CDKN2A, PTEN, and SMARCB1.
Choy E; MacConaill LE; Cote GM; Le LP; Shen JK; Nielsen GP; Iafrate AJ; Garraway LA; Hornicek FJ; Duan Z
PLoS One; 2014; 9(7):e101283. PubMed ID: 24983247
[TBL] [Abstract] [Full Text] [Related]
[Next]
